Perfil
Sigurd Okkels is the founder of two companies, Profound Pharma AS and Maxygen ApS, both founded in 1999.
At Profound Pharma AS, he held the title of Director-Science & Technology from 1999 to 2005.
At Maxygen ApS, he also held the title of Director-Science & Technology from 1999 to 2005.
Dr. Okkels's former jobs include Vice President at Takeda Pharmaceutical Co., Ltd.
from 2011 to 2017, Vice President-Technology at.
Takeda A from 2009 to 2011, and Senior Vice President-Product Development at Ascendis Pharma A from 2019 to 2023.
Dr. Okkels received a graduate degree and a doctorate from the University of Copenhagen.
Antiguos cargos conocidos de Sigurd Okkels.
| Empresas | Cargo | Fin |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 30/09/2023 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/12/2017 |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Director Técnico/Científico/I+D | 01/10/2011 |
| Maxygen ApS | Fundador | 01/05/2005 |
Profound Pharma AS
 Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | Fundador | 01/01/2005 |
Formación de Sigurd Okkels.
| University of Copenhagen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Empresas privadas | 3 |
|---|---|
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
| Maxygen ApS |
- Bolsa de valores
- Insiders
- Sigurd Okkels
